vs

Side-by-side financial comparison of Organogenesis Holdings Inc. (ORGO) and SOUTHERN FIRST BANCSHARES INC (SFST). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($37.2M vs $31.8M, roughly 1.2× SOUTHERN FIRST BANCSHARES INC). On growth, SOUTHERN FIRST BANCSHARES INC posted the faster year-over-year revenue change (26.1% vs -57.1%). Over the past eight quarters, SOUTHERN FIRST BANCSHARES INC's revenue compounded faster (22.2% CAGR vs -46.5%).

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

First Community Bankshares, Inc. is a $2.43 billion bank holding company and the parent company of First Community Bank of Bluefield, Virginia, in the United States. As of 2012 First Community Bank had 45 locations in Virginia, West Virginia, and North Carolina, and two locations operating as Peoples Community Bank in Tennessee. As of April 21, 2023, First Community had $3.6 billion in assets.

ORGO vs SFST — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.2× larger
ORGO
$37.2M
$31.8M
SFST
Growing faster (revenue YoY)
SFST
SFST
+83.2% gap
SFST
26.1%
-57.1%
ORGO
Faster 2-yr revenue CAGR
SFST
SFST
Annualised
SFST
22.2%
-46.5%
ORGO

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ORGO
ORGO
SFST
SFST
Revenue
$37.2M
$31.8M
Net Profit
Gross Margin
30.8%
Operating Margin
-185.1%
40.1%
Net Margin
Revenue YoY
-57.1%
26.1%
Net Profit YoY
EPS (diluted)
$1.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ORGO
ORGO
SFST
SFST
Q1 26
$37.2M
Q4 25
$225.6M
$31.8M
Q3 25
$150.9M
$31.1M
Q2 25
$101.0M
$28.6M
Q1 25
$86.7M
$26.5M
Q4 24
$126.7M
$25.2M
Q3 24
$115.2M
$23.8M
Q2 24
$130.2M
$23.1M
Net Profit
ORGO
ORGO
SFST
SFST
Q1 26
Q4 25
$43.7M
Q3 25
$21.6M
$8.7M
Q2 25
$-9.4M
$6.6M
Q1 25
$-18.8M
$5.3M
Q4 24
$7.7M
Q3 24
$12.3M
$4.4M
Q2 24
$-17.0M
$3.0M
Gross Margin
ORGO
ORGO
SFST
SFST
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
ORGO
ORGO
SFST
SFST
Q1 26
-185.1%
Q4 25
28.1%
40.1%
Q3 25
13.7%
36.4%
Q2 25
-12.5%
30.0%
Q1 25
-30.9%
26.1%
Q4 24
8.1%
27.3%
Q3 24
5.4%
24.1%
Q2 24
-10.7%
17.0%
Net Margin
ORGO
ORGO
SFST
SFST
Q1 26
Q4 25
19.4%
Q3 25
14.3%
27.8%
Q2 25
-9.3%
23.0%
Q1 25
-21.7%
19.9%
Q4 24
6.1%
Q3 24
10.7%
18.4%
Q2 24
-13.1%
13.0%
EPS (diluted)
ORGO
ORGO
SFST
SFST
Q1 26
Q4 25
$0.31
$1.19
Q3 25
$0.11
$1.07
Q2 25
$-0.10
$0.81
Q1 25
$-0.17
$0.65
Q4 24
$0.05
$0.69
Q3 24
$0.09
$0.54
Q2 24
$-0.13
$0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ORGO
ORGO
SFST
SFST
Cash + ST InvestmentsLiquidity on hand
$91.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$368.7M
Total Assets
$520.0M
$4.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ORGO
ORGO
SFST
SFST
Q1 26
$91.4M
Q4 25
$93.7M
Q3 25
$63.7M
Q2 25
$73.1M
Q1 25
$110.0M
Q4 24
$135.6M
Q3 24
$94.3M
Q2 24
$89.9M
Total Debt
ORGO
ORGO
SFST
SFST
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
ORGO
ORGO
SFST
SFST
Q1 26
Q4 25
$300.1M
$368.7M
Q3 25
$255.1M
$356.3M
Q2 25
$233.2M
$345.5M
Q1 25
$242.9M
$337.6M
Q4 24
$262.9M
$330.4M
Q3 24
$278.5M
$326.5M
Q2 24
$263.5M
$318.7M
Total Assets
ORGO
ORGO
SFST
SFST
Q1 26
$520.0M
Q4 25
$598.7M
$4.4B
Q3 25
$509.8M
$4.4B
Q2 25
$461.1M
$4.3B
Q1 25
$467.4M
$4.3B
Q4 24
$497.9M
$4.1B
Q3 24
$446.3M
$4.2B
Q2 24
$443.2M
$4.1B
Debt / Equity
ORGO
ORGO
SFST
SFST
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ORGO
ORGO
SFST
SFST
Operating Cash FlowLast quarter
$30.5M
Free Cash FlowOCF − Capex
$29.9M
FCF MarginFCF / Revenue
93.8%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$62.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ORGO
ORGO
SFST
SFST
Q1 26
Q4 25
$39.4M
$30.5M
Q3 25
$3.1M
$14.5M
Q2 25
$-32.9M
$10.5M
Q1 25
$-19.9M
$7.6M
Q4 24
$10.9M
$25.6M
Q3 24
$8.7M
$26.3M
Q2 24
$4.7M
$4.0M
Free Cash Flow
ORGO
ORGO
SFST
SFST
Q1 26
Q4 25
$34.8M
$29.9M
Q3 25
$844.0K
$14.4M
Q2 25
$-36.5M
$10.4M
Q1 25
$-23.6M
$7.4M
Q4 24
$7.6M
$24.8M
Q3 24
$6.1M
$26.1M
Q2 24
$2.9M
$3.9M
FCF Margin
ORGO
ORGO
SFST
SFST
Q1 26
Q4 25
15.4%
93.8%
Q3 25
0.6%
46.3%
Q2 25
-36.1%
36.3%
Q1 25
-27.2%
28.1%
Q4 24
6.0%
98.2%
Q3 24
5.3%
110.0%
Q2 24
2.2%
16.8%
Capex Intensity
ORGO
ORGO
SFST
SFST
Q1 26
Q4 25
2.1%
1.8%
Q3 25
1.5%
0.3%
Q2 25
3.6%
0.3%
Q1 25
4.2%
0.5%
Q4 24
2.7%
3.1%
Q3 24
2.2%
0.8%
Q2 24
1.4%
0.4%
Cash Conversion
ORGO
ORGO
SFST
SFST
Q1 26
Q4 25
0.90×
Q3 25
0.14×
1.67×
Q2 25
1.59×
Q1 25
1.44×
Q4 24
1.43×
Q3 24
0.71×
6.01×
Q2 24
1.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons